| Financial Year |
March 31 2023 |
| Monetary Funds |
780,475,611.89 |
| Held-for-trading Financial Assets |
587,535.02 |
| Notes Receivable |
31,330,615.60 |
| Accounts Receivable |
60,951,359.65 |
| Advances to Suppliers |
318,470,659.24 |
| Other Receivables |
4,154,763.46 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
529,684,902.06 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,862,125.04 |
| Total Current Assets |
1,728,517,571.96 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
22,376,069.59 |
| Long-term Equity Investment |
83,258,807.01 |
| Investment Properties |
-- |
| Fixed Assetes |
1,945,332,789.85 |
| Under-construction Projects |
57,208,562.57 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
256,795,725.54 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
40,444,505.99 |
| Deferred Income Tax Assets |
27,163,852.26 |
| Other Non-Current Assets |
44,595,126.00 |
| Sub-Total of Non-Current Assets |
2,515,103,765.37 |
| Total Assets |
4,243,621,337.33 |
| Short-Term Loans |
578,546,335.07 |
| Trading Financial liabilities |
-- |
| Notes Payable |
36,337,296.75 |
| Accounts Payable |
237,633,495.74 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
23,643,840.72 |
| Taxes Payable |
39,892,825.61 |
| Interest Payable |
-- |
| Dividend Payable |
9,626,338.93 |
| Other payables |
232,994,277.30 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
73,201,028.38 |
| Other Current Liabilities |
2,206,998.73 |
| Sub-Total of Current Liabilities |
1,229,443,550.03 |
| Long-term Loans |
76,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
119,997,456.45 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
704,038.71 |
| Other Non-Current Liabilities |
2,000,000.00 |
| Sub-Total of Non-Current Liabilities |
211,450,975.54 |
| Total Liabilities |
1,440,894,525.57 |
| Paid-In Capital(Or Share Stock) |
1,185,787,580.00 |
| Capital Surplus |
2,051,194,854.89 |
| Surplus Reserve |
144,330,756.20 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-586,690,806.13 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,802,726,811.76 |
| Owner's Equity（Stockholder's Equity） |
2,802,726,811.76 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,243,621,337.33 |
